FDA Inspection 1205970 — Alabama Center for Reproductive Medicine

Alabama Center for Reproductive Medicine — FEI 3015364206

The FDA completed an inspection of Alabama Center for Reproductive Medicine on May 18, 2023 in Birmingham, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 18, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Birmingham, AL (United States)